Literature DB >> 15967973

When prognosis precedes diagnosis: putting the cart before the horse.

Marc S Sabatine1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15967973      PMCID： PMC1150262          DOI： 10.1503/cmaj.050560

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  15 in total

1.  It's time for a change to a troponin standard.

Authors:  A S Jaffe; J Ravkilde; R Roberts; U Naslund; F S Apple; M Galvani; H Katus
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

2.  The search for a biomarker of cardiac ischemia.

Authors:  David A Morrow; James A de Lemos; Marc S Sabatine; Elliott M Antman
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

3.  Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia.

Authors:  Juan Quiles; Debashis Roy; David Gaze; Iris Paula Garrido; Pablo Avanzas; Manas Sinha; Juan Carlos Kaski
Journal:  Am J Cardiol       Date:  2003-08-01       Impact factor: 2.778

4.  Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome.

Authors:  Andrew Worster; P J Devereaux; Diane Heels-Ansdell; Gordon H Guyatt; John Opie; Farouk Mookadam; Stephen A Hill
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

5.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.

Authors:  D A Morrow; C P Cannon; N Rifai; M J Frey; R Vicari; N Lakkis; D H Robertson; D A Hille; P T DeLucca; P M DiBattiste; L A Demopoulos; W S Weintraub; E Braunwald
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

6.  Missed diagnoses of acute cardiac ischemia in the emergency department.

Authors:  J H Pope; T P Aufderheide; R Ruthazer; R H Woolard; J A Feldman; J R Beshansky; J L Griffith; H P Selker
Journal:  N Engl J Med       Date:  2000-04-20       Impact factor: 91.245

7.  Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.

Authors:  D Bar-Or; J V Winkler; K Vanbenthuysen; L Harris; E Lau; F W Hetzel
Journal:  Am Heart J       Date:  2001-06       Impact factor: 4.749

8.  Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia.

Authors:  D Bar-Or; G Curtis; N Rao; N Bampos; E Lau
Journal:  Eur J Biochem       Date:  2001-01

9.  Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.

Authors:  Manas K Sinha; David C Gaze; John R Tippins; Paul O Collinson; Juan Carlos Kaski
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

10.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

Authors:  Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690
View more
  1 in total

1.  Biological variation of ischaemia-modified albumin in healthy subjects.

Authors:  R Govender; J De Greef; R Delport; P J Becker; W J Vermaak
Journal:  Cardiovasc J Afr       Date:  2008 May-Jun       Impact factor: 1.167
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.